Article

FDA Approves Non-Opioid Injectable Painkiller

Food and Drug Administration (FDA) recently approved (PDF) DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics.

Food and Drug Administration (FDA)

recently approved

(PDF) Dyloject

TM

Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics,

reports

the drug’s manufacturer, Hospira, Inc. The drug is an injectable therapy that can be administered in 15 seconds. It comes at a time when federal and local governments are working to reduce abuse of prescription opioid medications, with related deaths climbing to 16,500 in 2010, reports

Reuters

.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit:  Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com